432 related articles for article (PubMed ID: 27619001)
1. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
[TBL] [Abstract][Full Text] [Related]
2. The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord.
Mika J; Rojewska E; Makuch W; Korostynski M; Luvisetto S; Marinelli S; Pavone F; Przewlocka B
Neuroscience; 2011 Feb; 175():358-66. PubMed ID: 21111791
[TBL] [Abstract][Full Text] [Related]
3. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain.
Mika J; Rojewska E; Makuch W; Przewlocka B
Neuroscience; 2010 Feb; 165(4):1420-8. PubMed ID: 19961904
[TBL] [Abstract][Full Text] [Related]
4. Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies.
Piotrowska A; Kwiatkowski K; Rojewska E; Makuch W; Mika J
Neuropharmacology; 2016 Sep; 108():207-19. PubMed ID: 27117708
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.
Jurga AM; Rojewska E; Makuch W; Mika J
Pharm Biol; 2018 Dec; 56(1):275-286. PubMed ID: 29656686
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal administration of botulinum toxin type a antagonizes neuropathic pain by countering increased vesicular nucleotide transporter expression in the spinal cord of chronic constriction injury of the sciatic nerve rats.
Shi Y; Gong C; Nan W; Zhou W; Lei Z; Zhou K; Wang L; Zhao G; Zhang H
Neuropeptides; 2023 Aug; 100():102346. PubMed ID: 37178626
[TBL] [Abstract][Full Text] [Related]
7. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
[TBL] [Abstract][Full Text] [Related]
8. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
9. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.
Zajaczkowska R; Kwiatkowski K; Pawlik K; Piotrowska A; Rojewska E; Makuch W; Wordliczek J; Mika J
Pharmacol Rep; 2020 Oct; 72(5):1310-1322. PubMed ID: 32691345
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
11. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Pawlik K; Piotrowska A; Kwiatkowski K; Ciapała K; Popiolek-Barczyk K; Makuch W; Mika J
Immunology; 2020 Apr; 159(4):413-428. PubMed ID: 31919846
[TBL] [Abstract][Full Text] [Related]
12. The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Mika J
J Neuroimmune Pharmacol; 2017 Sep; 12(3):402-419. PubMed ID: 28337574
[TBL] [Abstract][Full Text] [Related]
13. Dataset of botulinum toxin A influence on interleukins under neuropathy.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Data Brief; 2016 Dec; 9():1020-1023. PubMed ID: 27900354
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures.
Piotrowska A; Popiolek-Barczyk K; Pavone F; Mika J
Front Cell Infect Microbiol; 2017; 7():141. PubMed ID: 28491822
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model.
Finocchiaro A; Marinelli S; De Angelis F; Vacca V; Luvisetto S; Pavone F
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29562640
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-
Piotrowska A; Ciapała K; Pawlik K; Kwiatkowski K; Rojewska E; Mika J
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681732
[TBL] [Abstract][Full Text] [Related]
17. Pulsed Radiofrequency on Dorsal Root Ganglion Relieved Neuropathic Pain Associated with Downregulation of the Spinal Interferon Regulatory Factor 8, Microglia, p38MAPK Expression in a CCI Rat Model.
Liu R; Xu X; Xu Y; Fang X; Lin X
Pain Physician; 2018 Jul; 21(4):E307-E322. PubMed ID: 30045596
[TBL] [Abstract][Full Text] [Related]
18. The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Przewlocka B; Mika J
Eur J Pharmacol; 2015 Feb; 749():115-23. PubMed ID: 25460025
[TBL] [Abstract][Full Text] [Related]
19. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model.
Rojewska E; Piotrowska A; Makuch W; Przewlocka B; Mika J
Neuropharmacology; 2016 Mar; 102():80-91. PubMed ID: 26524415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
